Aureum Therapeutics

Aureum Therapeutics is a clinical-stage biotechnology company dedicated to leveraging pregnancy immunology as a framework for developing innovative healing solutions for cancer and recurrent miscarriage. By studying how the maternal immune system naturally tolerates a genetically distinct fetus, the company is pioneering placenta-based and tolerance-restoring approaches. Aureum's pipeline includes two clinical-stage oncology programs focused on a placenta-based immunotherapy that selectively targets tumor-feeding blood vessels, as well as two preclinical programs targeting recurrent miscarriage. Notably, the company is developing NomiCell, an umbilical cord mesenchymal stem cell (MSC) product optimized for enhanced immune modulatory activity to prevent pregnancy loss.